Faces of Digital Health
Healthcare Digitalization in the Middle East 1/2: What Contributes to Rapid Development? (Ziad Tabet)
In the next two episodes, we’ll dive into healthcare development a digitalization in the Middle East. You’re going to hear from two speakers based in Dubai. The speaker of today’s episode is Ziad Tabet, Chief Customer Officer at Alliance Care Technologies. Ziad is a healthcare veteran with three decades of experience spanning many aspects of the healthcare space. He has extensive experience in operations and financial management of hospital systems, healthcare start-ups, sales and business development, account management, creating and bringing infrastructure and teams from idea to reality. Ziad has been living in UAE for over ten years, first in Abu Dhabi now in Dubai. In this discussion, he shared his experience in the region, commented on opportunities and mindset around digitalization.
www.facesofdigitalhealth.com
www.lovethepodcast.com/facesofdigitalhealth
EIT Health Germany Series 2/12: Improving Medication Prescribing With Digital Twins (ExactCure)
Unsafe medication practices and medication errors are a leading cause of injury and avoidable harm in health care systems across the world. Exactcure is a digital health startup from France addressing the challenge of preventing the negative effects of medications. The company is building a digital twin simulator, that shows the effects and interactions of drugs in the body of an individual. They take into account any data the patient can provide, from basic personal characteristics such as age, gender, kidney status, genotype, if a person smokes or not, or any other individual parameter that has a proven influence on a specific medication. I spoke with Fabien Astic, Chief Business Development Officer at ExactCure, and Margaux Kerhousse, Business Developer at ExactCure, about the company’s journey, partnerships, and how their solution could fit into the existing prescribing workflows.
This is the second out of 12 episodes supported by EIT Health Germany. EIT Health Germany is one of eight Knowledge and Innovation Communities (KICs) currently funded by the European Institute of Innovation and Technology (EIT). EIT Health Germany connects 150 renowned partners from industry, research, and education from Germany, Austria, and Switzerland. If you’re a startup working in the field of digital health or biotech and don’t know EiT Health Germany yet, eit-health.de, where you will find more about innovation, acceleration, and education programs.
Exactcure participated in several EIT Health Germany programs. Among others you will hear about is the Startups meet Healthcare Providers programs, which aims to bridge the gap between startups and clinicians. This can help shorten the time it takes for innovators to start testing their solutions in practice. To learn more about this program, go to the link in the show notes. Many application deadlines close in March, so do check out the links for opportunities right for you:
- All EIT Health Germany 2022 opportunities: https://eit-health.de/en/accelerator-2/
- Startups meet healthcare providers: https://eithealth.eu/programmes/start-ups-meet-healthcare-providers/
www.facesofdigitalhealth.com
Recap of the episode: www.facesofdigitalhealth.com/blog/eit-health-germany-medication-prescribing-digital-twins-exactcure
Leave a rating or review: www.lovethepodcast.com/facesofdigitalhealth
Clubhouse, Digital Therapeutics and How Can We Speed Un Innovation Adoption (Jhonathan Bringas, Diana Van Stijn)
If you took part in the Clubhouse frenzy last year, you probably came across the Digital Health Channel. Digital Health Channel which currently has 6400 members, was among the key digital health topics related hubs on Clubhouse with an active schedule of discussions each week. It was founded by two medical doctors – Jhonatan Bringas and Diana van Stijn, who many may not know, are a married couple. While the Digital Health Channel is not active anymore, Diana and Jhonatan are continuing their pursuit of bridging the gap between medical practice and innovation. They work with Medscape and occasionally facilitate digital health-related discussions. They’re the co-founders of Lapsi health, a digital health startup that was first looking at a digital therapeutic solution for asthma in children but is now pivoting in the space of digital biomarkers. Most of the time, however, Diana works as a clinical resident at Amsterdam UMC Hospital and Jhonathan as the digital health consultant and lecturer. In today’s short discussion you’re going to hear a bit more about their journey, perspective on digital therapeutics, and bridging the gap between academia and the industry to accelerate healthcare innovation.
More on the website:
Why Should We Care About Open AI in Healthcare? (Bart De Witte, Hippo AI Foundation)
The positive potentials of AI in healthcare are breathtaking. From smoother processes to more accurate care with fewer medical errors. But if we learned anything from the last 15 years of living with social media, it is that the development of algorithms without proper regulation can have negative impacts on society. In healthcare, AI development is still in the early stages. Many regulation-related questions still need to be addressed. It is not easy to create regulation, because it needs to take into account all sorts of aspects: safety, trust, values of the environment it is designed for. In today’s episode, you’ll hear a discussion with Bart de Witte – Founder of Hippo AI foundation – a non-profit organization that fights for making medical knowledge openly available and AI-based healthcare a common good. This is a diametrically opposing approach to the direction of current medical AI developments — the majority of which focus on the privatization of medical knowledge. Bart and I discussed what exactly does it mean to have open AI models, how can we create an environment to support that, the state of AI regulation in Europe, and more.
Learn more about the Hippo AI Foundation: https://www.hippoai.org/
The European artificial intelligence strategy: implications and challenges for digital health: https://www.thelancet.com/journals/landig/article/PIIS2589-7500(20)30112-6/fulltext
EiT Health Germany Series 1/12: Changing The Paradigm in the Fight Against Antimicrobial Resistance (Alexander Belcredi)
Antimicrobial resistance is a global problem related to the overuse of antibiotics and the lack of development of new ones. Many solutions are entering the market to address the issue: software solutions to identify, track and predict antibiotic-resistant infections and help prescribers with more accurate prescribing of antibiotics.
Antibiotics are not appealing to the pharmaceutical industry from a business perspective. The reason is that new antibiotics are intended for a fraction of all patients. So if you develop a drug that’s meant to be used as the last resort for clinicians after they’ve tried all other options, clinicians would more often than not try to avoid using these new antibiotics if not absolutely necessary.
Among the problems with antibiotics is the fact that many are very broad-spectrum, used to kill several different bacteria. So in this episode, we’re going to change the paradigm of antimicrobial treatments: what if you could target harmful bacteria more precisely? You’ll hear from Alexander Belcredi, co-founder and Co-CEO of the biotech startup PhagoMed, which was acquired by BioNTech and renamed BioNTech R&D Austria in October 2021. Phagomed has been researching the field of antimicrobials and also developed an innovative treatment for bacterial vaginosis. In today’s discussion, you’ll hear about the challenges with the development of antimicrobial therapies, and also learn more about Phagomed’s journey before the acquisition.
This episode is supported by EiT Health Germany, which is one of eight Knowledge and Innovation Communities (KICs) currently funded by the European Institute of Innovation and Technology (EIT). EiT Health Germany connects 150 renowned partners from industry, research and education from Germany, Austria and Switzerland. The unique network helps initiate outstanding innovations in the health sector. If you’re a startup working in the field of digital health or biotech and don’t know EiT Health Germany yet, I would encourage you to visit eit-health.de, where you will find more about innovation, acceleration, and education programs.
Learn more:
- EiT Catapult Program: https://eit-health.de/en/eit-health-catapult-2021/
- EiT Health Germany: https://eit-health.de/en/
More about antimicrobial resistance:
How Can We Optimize the Use of Antibiotics? (Oliver Schacht, OpGen): https://www.facesofdigitalhealth.com/blog/f130-how-can-we-optimize-the-use-of-antibiotics-oliver-schacht-opgen?rq=antibiotic
US Clinicians: Reflect on how this Podcast applies to your day-to-day and earn AMA PRA Category 1 CMEs here: https://earnc.me/UpR9lQ
How Do You Make Decisions in Healthcare? (Talya Miron-Shatz)
Have you ever had the experience of not knowing how to decide about your medical condition? Or when you went to the doctor’s and haven’t asked half of the things you remembered might be useful to know when you returned home? Maybe you’re an app developer trying to figure out how to prevent churn and have a lasting user engagement with your health app? In today’s episode, you’ll hear from Talya Miron- Shatz, PhD, an expert in medical decision making, and author of a new book titled “Your Life Depends on It: What You Can Do to Make Better Choices About Your Health.” She talks about why physicians and patients need to abandon old behavior patterns that no longer work and learn to help each other make better collaborative choices.
In this discussion, Dr. Miron-Shatz discusses the latest findings about health choices and medical decisions, how can doctors talk to patients so they will leave the doctor’s office informed and we ended the discussion with three questions you should practice before going to see a doctor.
Leave a rating or a review: www.lovethepodcast.com/facesofdigitalhealth
Episode recap: https://www.facesofdigitalhealth.com/blog/what-to-ask-the-doctor
Responses